iRadimed (FRA:46K) E10: €0.83 (As of Mar. 2026)


FRA:46K iRadimed Corp FRA:46K
87 GF Score
Price €84.50
GF Value €56.02
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is iRadimed E10?

iRadimed FRA:46K +1.81% 87 E10 is €0.83 as of Mar. 2026. GuruFocus rates FRA:46K with a GF Score™ of 87/100 and a GF Value™ of €56.02 (Significantly Overvalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

iRadimed's adjusted earnings per share data for the three months ended in Mar. 2026 was €0.389. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €0.83 for the trailing ten years ended in Mar. 2026.

During the past 12 months, iRadimed's average E10 Growth Rate was 14.00% per year. During the past 3 years, the average E10 Growth Rate was 19.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of iRadimed was 19.60% per year. The lowest was 19.60% per year. And the median was 19.60% per year.

As of today (2026-07-11), iRadimed's current stock price is €84.50. iRadimed's E10 for the quarter that ended in Mar. 2026 was €0.83. iRadimed's Shiller PE Ratio of today is 101.81.

During the past 13 years, the highest Shiller PE Ratio of iRadimed was 110.17. The lowest was 51.44. And the median was 67.99.


iRadimed  (FRA:46K) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

iRadimed's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=84.50/0.83
=101.81

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of iRadimed was 110.17. The lowest was 51.44. And the median was 67.99.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


iRadimed E10 Related Terms


iRadimed E10 Historical Data

* Premium members only.

The historical data trend for iRadimed's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

iRadimed E10 Chart

iRadimed Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.52 0.59 0.77 0.80

iRadimed Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.79 0.77 0.76 0.80 0.83

FRA:46K vs AVNS, LMRI, AORT: E10 Comparison

For the Medical Devices subindustry, iRadimed's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


iRadimed Shiller PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, iRadimed's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where iRadimed's Shiller PE Ratio falls into.


FRA:46K
87GF Score
iRadimed Corp FRA:46K
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

iRadimed E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, iRadimed's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.389/330.2130*330.2130
=0.389

Current CPI (Mar. 2026) = 330.2130.

iRadimed Quarterly Data

per share eps CPI Adj_EPS
201606 0.169 241.018 0.232
201609 0.116 241.428 0.159
201612 0.095 241.432 0.130
201703 -0.019 243.801 -0.026
201706 0.027 244.955 0.036
201709 0.017 246.819 0.023
201712 0.017 246.524 0.023
201803 0.057 249.554 0.075
201806 0.094 251.989 0.123
201809 0.171 252.439 0.224
201812 0.123 251.233 0.162
201903 0.133 254.202 0.173
201906 0.150 256.143 0.193
201909 0.182 256.759 0.234
201912 0.234 256.974 0.301
202003 0.127 258.115 0.162
202006 -0.151 257.797 -0.193
202009 0.076 260.280 0.096
202012 0.041 260.474 0.052
202103 0.092 264.877 0.115
202106 0.100 271.696 0.122
202109 0.170 274.310 0.205
202112 0.274 278.802 0.325
202203 0.182 287.504 0.209
202206 0.246 296.311 0.274
202209 0.273 296.808 0.304
202212 0.274 296.797 0.305
202303 0.252 301.836 0.276
202306 0.305 305.109 0.330
202309 0.375 307.789 0.402
202312 0.330 306.746 0.355
202403 0.294 312.332 0.311
202406 0.353 314.175 0.371
202409 0.360 315.301 0.377
202412 0.382 315.605 0.400
202503 0.342 319.799 0.353
202506 0.390 322.561 0.399
202509 0.366 324.800 0.372
202512 0.427 324.054 0.435
202603 0.389 330.213 0.389

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €0.83 mean?
iRadimed (FRA:46K) has a E10 of €0.83 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on iRadimed and its competitors.
Is iRadimed's E10 too high?
iRadimed's current E10 is €0.83. Overall, iRadimed has a GF Score™ of 87/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does iRadimed's E10 compare to AVNS and LMRI?
iRadimed's E10 of €0.83 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Devices & Instruments company?
A good E10 depends on the Medical Devices & Instruments industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on iRadimed and its competitors. iRadimed's current E10 is €0.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iRadimed stock overvalued right now?
Based on GuruFocus' analysis, iRadimed (FRA:46K) is currently considered Significantly Overvalued. The stock's GF Value™ is €56.02, compared to a current price of €84.50 — trading 50.8% above its estimated fair value. The current E10 is €0.83. iRadimed's overall GF Score™ is 87/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For iRadimed (FRA:46K), the current E10 is €0.83 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is iRadimed (FRA:46K) Overvalued in 2026?

Based on GuruFocus' analysis, iRadimed stock appears to be overvalued. The current stock price of €84.50 is trading 50.8% above its estimated GF Value™ of €56.02. GuruFocus considers iRadimed to be Significantly Overvalued.

Key valuation signals for FRA:46K:

  • E10: €0.83
  • GF Value™: €56.02 vs. price of €84.50 (50.8% above fair value)
  • GF Score™: 87/100 with 6 warning signs

No single metric tells the full story. See the FRA:46K stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


iRadimed Business Description

Other Exchanges IRMD:USA
Address 12705 Ingenuity Drive, Orlando, FL, USA, 32826
iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.
87GF Score

Get the complete analysis for FRA:46K

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€84.50
Price
€56.02
GF Value